HPR190 Evaluating the Impact of the Entry of IVD-R in the Biopharmaceutical Industry, With a Focus on Evidence Requirements and Time to Launch
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1319
https://www.valueinhealthjournal.com/article/S1098-3015(22)03524-0/fulltext
Title :
HPR190 Evaluating the Impact of the Entry of IVD-R in the Biopharmaceutical Industry, With a Focus on Evidence Requirements and Time to Launch
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03524-0&doi=10.1016/j.jval.2022.09.1319
First page :
Section Title :
Open access? :
No
Section Order :
10862